A potential impurity found in commercial preparations of olanzapine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Olanzapine-related Compound B

Item No. 33786

Technical Information
Formal Name
5,10-dihydro-2-methyl-4H-thieno[2,3-b][1,5]benzodiazepin-4-one
CAS Number
221176-49-4
Synonyms
  • LY301664
Molecular Formula
C12H10N2OS
Formula Weight
Purity
≥98%
A solid
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS (pH 7.2) (1:3): 0.25 mg/mlEthanol: 15 mg/ml
λmax
231, 262 nm
SMILES
O=C1NC2=C(NC3=C1C=C(C)S3)C=CC=C2
InChi Code
InChI=1S/C12H10N2OS/c1-7-6-8-11(15)13-9-4-2-3-5-10(9)14-12(8)16-7/h2-6,14H,1H3,(H,13,15)
InChi Key
LVTDAJJOMLNXFS-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Olanzapine-related compound B is a potential impurity found in commercial preparations of olanzapine.1 It is a degradation product formed by exposure to oxidative stress.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hiriyanna, S.G., Basavaiah, K., Goud, P.S.K., et alIdentification and characterization of olanzapine degradation products under oxidative stress conditions. Acta Chromatagr. 20(1), 81–93 (2008).